Company Presentation

Orion Biotechnology is a clinical stage company founded in 2017, with established R&D operations in Geneva, Switzerland and headquarters in Ottawa, Canada.
Orion is the only company with a novel approach to target previously undruggable small protein GPCRs. Enabled by our proprietary PROcisionXTM platform, we offer one of the fastest drug discovery solutions in industry to target small protein GPCRs.
Orion has a strong pipeline with diversity across development stages.